Northwell Health Opens $6M New Interventional Radiology Suite

Why It Matters

The suite expands minimally invasive options, improves diagnostic precision for cancer, and solidifies Northwell’s standing as a leading oncology care provider.

Key Takeaways

• $6M, 1,100‑sq‑ft IR suite opened at Long Island Jewish.
• Philips Azurion 7 provides 3D imaging with eight‑axis rotation.
• Enables advanced cancer biopsies and neurointerventions with lower radiation.
• Third IR suite at LIJ, expanding Northwell’s minimally invasive portfolio.
• Complements $3M IR suite at Huntington, supporting 19,000 annual cancer cases.

Pulse Analysis

Northwell Health’s $6 million interventional radiology (IR) suite at Long Island Jewish Medical Center marks a notable escalation in the health system’s imaging capabilities. The 1,100‑square‑foot space houses a Philips Azurion 7 platform, a high‑end, eight‑axis, 3‑D image‑guided system that rivals equipment found in major academic centers. By pairing the scanner with upgraded IT infrastructure and a dedicated recovery area, Northwell not only modernizes its existing IR footprint but also signals a broader industry shift toward capital‑intensive, technology‑driven minimally invasive care.

The clinical upside is immediate. The Azurion 7’s superior image quality and dose‑reduction features enable physicians to perform more precise cancer biopsies and complex neuro‑interventions, directly benefiting the 19,000 oncology patients Northwell treats each year. Lower radiation exposure improves safety for both patients and staff, while the expanded suite shortens procedure times and reduces hospital stays. For a system that already operates 28 hospitals and serves 80,000 in‑patients annually, the new suite strengthens its reputation as a leading cancer treatment hub.

From a market perspective, Northwell’s investment mirrors a national trend where health systems allocate multi‑million‑dollar budgets to advanced IR suites to stay competitive. The $3 million suite opened earlier at Huntington Hospital demonstrates a phased rollout strategy that balances cost with incremental capability gains. As insurers increasingly reward minimally invasive procedures for their cost‑effectiveness, hospitals that can offer cutting‑edge IR are poised to capture higher referral volumes and improve payer contracts. In the long run, the technology could drive revenue growth while delivering measurable quality improvements.